Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

NCT04448522 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

508

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Radiotherapy
Chemotherapy

Interventions

RADIATION: reduced dosage IMRT
RADIATION: conventional dosage IMRT

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]